Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Panosyan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Transplantation|May 12, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLAEduard H Panosyan, Alan K Ikeda, Vivian Y Chang, et al.
Journal of Neuro-Oncology|February 29, 2016
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acidsEduard H Panosyan, Joseph L Lasky, Henry J Lin, et al.
Pediatric Blood & Cancer|July 1, 2010
Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formationEduard H Panosyan, Dan R Laks, Michael Masterman-Smith, et al.
Journal of Pediatric Hematology/Oncology|April 14, 2020
Primary Renal Ewing Sarcoma in Children and Young AdultsKathryn Bradford, Alexander Nobori, Brittany Johnson, et al.
Molecular Cancer Research : MCR|February 8, 2014
Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumorsEduard H Panosyan, Yuntao Wang, Peng Xia, et al.
Cancer|August 27, 2015
Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group reportRichard H Ko, Tamekia L Jones, David Radvinsky, et al.
Molecular Cancer Therapeutics|August 24, 2011
A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cellsKoppany Visnyei, Hideyuki Onodera, Robert Damoiseaux, et al.
Journal of Pediatric Hematology/Oncology|April 17, 2004
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961Eduard H Panosyan, Nita L Seibel, Sagrario Martin-Aragon, et al.
Cancer Research and Treatment|January 9, 2025
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem CellsMichael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, et al.
The New England Journal of Medicine|July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell DiseaseYutaka Niihara, Scott T Miller, Julie Kanter, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Transplantation|May 12, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLAEduard H Panosyan, Alan K Ikeda, Vivian Y Chang, et al.
Journal of Neuro-Oncology|February 29, 2016
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acidsEduard H Panosyan, Joseph L Lasky, Henry J Lin, et al.
Pediatric Blood & Cancer|July 1, 2010
Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formationEduard H Panosyan, Dan R Laks, Michael Masterman-Smith, et al.
Journal of Pediatric Hematology/Oncology|April 14, 2020
Primary Renal Ewing Sarcoma in Children and Young AdultsKathryn Bradford, Alexander Nobori, Brittany Johnson, et al.
Molecular Cancer Research : MCR|February 8, 2014
Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumorsEduard H Panosyan, Yuntao Wang, Peng Xia, et al.
Cancer|August 27, 2015
Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group reportRichard H Ko, Tamekia L Jones, David Radvinsky, et al.
Molecular Cancer Therapeutics|August 24, 2011
A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cellsKoppany Visnyei, Hideyuki Onodera, Robert Damoiseaux, et al.
Journal of Pediatric Hematology/Oncology|April 17, 2004
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961Eduard H Panosyan, Nita L Seibel, Sagrario Martin-Aragon, et al.
Cancer Research and Treatment|January 9, 2025
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem CellsMichael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, et al.
The New England Journal of Medicine|July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell DiseaseYutaka Niihara, Scott T Miller, Julie Kanter, et al.
Pageof 3